Table Of Contents
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 Data Triangulation
2.2 Market Estimation Methodology
2.3 Market Growth Rate Projections
2.4 Research Assumptions
3 Executive Summary
4 Premium Insights
4.1 Influenza Diagnostics Market Overview
4.2 North America: Influenza Diagnostics Market Share, By Test Type & Country (2019)
4.3 Influenza Diagnostics Market Share, By End User (2019)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence Of Influenza
5.2.1.2 Growth In Influenza Research
5.2.1.3 Rising Demand For Rapid Disease Diagnosis
5.2.2 Restraints
5.2.2.1 Variability In Test Sensitivity And Specificity
5.2.2.2 Stringent Regulatory Framework
5.2.2.3 Rising Healthcare Costs
5.2.3 Opportunities
5.2.3.1 Advancements In Genomic And Proteomic Technologies
5.2.3.2 Significant Growth Prospects In Developing Countries
5.2.4 Challenges
5.2.4.1 Lack Of Skilled Professionals
5.3 The Impact Of Covid-19 Outbreak On The Growth Of Influenza Diagnostics Market
5.3.1 Similarities In Influenza And Covid-19 Symptoms
5.3.2 Who Recommendations For The Co-Testing Of Covid-19 And Other Respiratory Pathogens, Including Influenza And Rsv
5.3.3 Increased Adoption Of The Influenza Vaccine (Flu Shot) In The Healthcare System
5.3.4 Increasing Focus Of Diagnostic Manufacturers On The Development Of New Covid-19 Tests
6 Influenza Diagnostics Market, By Test Type
6.1 Introduction
6.2 Traditional Diagnostic Tests
6.2.1 Ridt
6.2.1.1 Ridt Tests Are Widely Used Owing To Their Ease Of Use And Rapid Interpretability Of Results
6.2.2 Viral Culture
6.2.2.1 Wide Use Of Viral Culture As A Confirmatory Test To Ensure The Results Of Ridt To Drive Market Growth
6.2.3 Dfa
6.2.3.1 Adoption Of Dfa Tests Is Increasing Due To Their Higher Sensitivity As Compared To Ridt
6.2.4 Serological Assays
6.2.4.1 Development Of Lab-On-Chip-Based Multiplex Assays To Support Market Growth
6.3 Molecular Diagnostic Tests
6.3.1 Rt-Pcr
6.3.1.1 Ability Of Rt-Pcr To Distinguish Between Influenza A And B Viruses Driving Its Adoption In Clinical Settings
6.3.2 Isothermal Nucleic Acid Amplification Tests
6.3.2.1 Transcription-Mediated Amplification-Based Assays
6.3.2.1.1 Tma Accounts For The Largest Share Of The Inaat Market
6.3.2.2 Loop-Mediated Isothermal Amplification-Based Assays
6.3.2.2.1 Rapidity, Stability, And Sensitivity Have Driven The Use Of Lamp
6.3.2.3 Nucleic Acid Sequence-Based Amplification Tests
6.3.2.3.1 Nasba Is Highly Preferred In Hospital And Clinical Settings As It Reduces The Need For Additional Reverse Transcription Steps
6.3.2.4 Other Inaat Tests
6.3.3 Other Molecular Tests
7 Influenza Diagnostics Market, By End User
7.1 Introduction
7.2 Hospitals
7.2.1 Hospitals Accounted For The Largest Share Of The Market In 2019
7.3 Clinical Laboratories
7.3.1 Advantages Offered By Clinical Laboratories In Terms Of Service Costs And Turnaround Time To Support Market Growth
7.4 Other End Users
8 Influenza Diagnostics Market, By Region
8.1 Introduction
8.2 North America
8.2.1 Us
8.2.1.1 The Us Dominated The North American Market In 2019
8.2.2 Canada
8.2.2.1 Government Initiatives And Technological Advancements In Diagnostic Techniques To Support Market Growth
8.3 Europe
8.3.1 France
8.3.1.1 Supportive Government Policies Drive Market Growth In France
8.3.2 Uk
8.3.2.1 Frequent Influenza Outbreaks In The Uk To Boost The Growth Of The Influenza Diagnostics Market
8.3.3 Roe
8.4 Asia Pacific
8.4.1 Increasing Healthcare Expenditure And Rising Awareness Indicate Favorable Prospects For Market Growth
8.5 Rest Of The World
9 Competitive Landscape
9.1 Introduction
9.2 Market Ranking Analysis, 2019
9.3 Competitive Leadership Mapping
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Dynamic Differentiators
9.3.4 Emerging Companies
9.4 Competitive Scenario
9.4.1 Key Product Approvals
9.4.2 Key Acquisitions
10 Company Profiles
10.1 F. Hoffmann-La Roche Ag
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Mnm View
10.2 Quidel Corporation
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.2.4 Mnm View
10.3 Thermo Fisher Scientific, Inc.
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Mnm View
10.4 Abbott Laboratories, Inc.
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.5 Hologic, Inc.
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.6 Becton, Dickinson And Company
10.6.1 Business Overview
10.6.2 Products Offered
10.6.3 Recent Developments
10.7 Danaher Corporation
10.7.1 Business Overview
10.7.2 Products Offered
10.7.3 Recent Developments
10.8 Diasorin Sa
10.8.1 Business Overview
10.8.2 Products Offered
10.9 Meridian Bioscience
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.1 Luminex Corporation
10.10.1 Business Overview
10.10.2 Products Offered
10.11 Biomérieux Sa
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.12 Genmark Diagnostics, Inc.
10.12.1 Business Overview
10.12.2 Products Offered
10.12.3 Recent Developments
10.13 Siemens Healthineers
10.13.1 Business Overview
10.13.2 Products Offered
10.13.3 Recent Developments
10.14 Tecan Trading
10.14.1 Business Overview
10.14.2 Products Offered
10.15 Sekisui Diagnostics
10.15.1 Business Overview
10.15.2 Products Offered
10.16 Sa Scientific, Ltd.
10.16.1 Business Overview
10.16.2 Products Offered
10.17 Altona Diagnostics Gmbh
10.17.1 Business Overview
10.17.2 Products Offered
10.18 Coris Bioconcept Sprl
10.18.1 Business Overview
10.18.2 Products Offered
10.19 Elitech Group
10.19.1 Business Overview
10.19.2 Products Offered
10.20 Mast Group Ltd.
10.20.1 Business Overview
10.20.2 Products Offered
10.21 Right-To-Win
11 Appendix
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details
List Of Tables
Table 1 Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 2 Traditional Diagnostic Tests Market, By Region, 2018–2025 (Usd Million)
Table 3 North America: Traditional Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 4 Europe: Traditional Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 5 Asia Pacific: Traditional Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 6 Traditional Diagnostic Tests Market, By Type, 2018–2025 (Usd Million)
Table 7 Ridt Market, By Region, 2018–2025 (Usd Million)
Table 8 North America: Ridt Market, By Country, 2018–2025 (Usd Million)
Table 9 Europe: Ridt Market, By Country, 2018–2025 (Usd Million)
Table 10 Viral Culture Market, By Region, 2018–2025 (Usd Million)
Table 11 North America: Viral Culture Market, By Country, 2018–2025 (Usd Million)
Table 12 Europe: Viral Culture Market, By Country, 2018–2025 (Usd Million)
Table 13 Dfa Market, By Region, 2018–2025 (Usd Million)
Table 14 North America: Dfa Market, By Country, 2018–2025 (Usd Million)
Table 15 Europe: Dfa Market, By Country, 2018–2025 (Usd Million)
Table 16 Serological Assays Market, By Region, 2018–2025 (Usd Million)
Table 17 North America: Serological Assays Market, By Country, 2018–2025 (Usd Million)
Table 18 Europe: Serological Assays Market, By Country, 2018–2025 (Usd Million)
Table 19 Molecular Diagnostic Tests Market, By Region, 2018–2025 (Usd Million)
Table 20 North America: Molecular Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 21 Europe: Molecular Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 22 Asia Pacific: Molecular Diagnostic Tests Market, By Country, 2018–2025 (Usd Million)
Table 23 Molecular Diagnostic Tests Market, By Type, 2018–2025 (Usd Million)
Table 24 Rt-Pcr Market, By Region, 2018–2025 (Usd Million)
Table 25 North America: Rt-Pcr Market, By Country, 2018–2025 (Usd Million)
Table 26 Europe: Rt-Pcr Market, By Country, 2018–2025 (Usd Million)
Table 27 Inaat Market, By Region, 2018–2025 (Usd Million)
Table 28 North America: Inaat Market, By Country, 2018–2025 (Usd Million)
Table 29 Europe: Inaat Market, By Country, 2018–2025 (Usd Million)
Table 30 Inaat Market, By Type, 2018–2025 (Usd Million)
Table 31 Tma Assays Market, By Region, 2018–2025 (Usd Million)
Table 32 North America: Tma Assays Market, By Country, 2018–2025 (Usd Million)
Table 33 Lamp Assays Market, By Region, 2018–2025 (Usd Million)
Table 34 North America: Lamp Assays Market, By Country, 2018–2025 (Usd Million)
Table 35 Nasba Tests Market, By Region, 2018–2025 (Usd Million)
Table 36 North America: Nasba Tests Market, By Country, 2018–2025 (Usd Million)
Table 37 Other Inaat Tests Market, By Region, 2018–2025 (Usd Million)
Table 38 North America: Other Inaat Tests Market, By Country, 2018–2025 (Usd Million)
Table 39 Other Molecular Tests Market, By Region, 2018–2025 (Usd Million)
Table 40 North America: Other Molecular Tests Market, By Country, 2018–2025 (Usd Million)
Table 41 Europe: Other Molecular Tests Market, By Country, 2018–2025 (Usd Million)
Table 42 Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 43 Influenza Diagnostics Market For Hospitals, By Region, 2018–2025 (Usd Million)
Table 44 North America: Influenza Diagnostics Market For Hospitals, By Country, 2018–2025 (Usd Million)
Table 45 Europe: Influenza Diagnostics Market For Hospitals, By Country, 2018–2025 (Usd Million)
Table 46 Influenza Diagnostics Market For Clinical Laboratories, By Region, 2018–2025 (Usd Million)
Table 47 North America: Influenza Diagnostics Market For Clinical Laboratories, By Country, 2018–2025 (Usd Million)
Table 48 Europe: Influenza Diagnostics Market For Clinical Laboratories, By Country, 2018–2025 (Usd Million)
Table 49 Influenza Diagnostics Market For Other End Users, By Region, 2018–2025 (Usd Million)
Table 50 North America: Influenza Diagnostics Market For Other End Users, By Country, 2018–2025 (Usd Million)
Table 51 Europe: Influenza Diagnostics Market For Other End Users, By Country, 2018–2025 (Usd Million)
Table 52 Influenza Diagnostics Market, By Region, 2018–2025 (Usd Million)
Table 53 Influenza Diagnostics Market, By Country, 2018–2025 (Usd Million)
Table 54 North America: Influenza Diagnostics Market, By Country, 2018–2025 (Usd Million)
Table 55 North America: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 56 North America: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 57 North America: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 58 North America: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 59 North America: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 60 Us: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 61 Us: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 62 Us: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 63 Us: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 64 Us: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 65 Canada: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 66 Canada: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 67 Canada: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 68 Canada: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 69 Canada: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 70 Europe: Influenza Diagnostics Market, By Country, 2018–2025 (Usd Million)
Table 71 Europe: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 72 Europe: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 73 Europe: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 74 Europe: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 75 Europe: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 76 France: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 77 France: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 78 France: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 79 France: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 80 Uk: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 81 Uk: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 82 Uk: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 83 Uk: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 84 Roe: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 85 Roe: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 86 Roe: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 87 Roe: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 88 Asia Pacific: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 89 Asia Pacific: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 90 Asia Pacific: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 91 Asia Pacific: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 92 Asia Pacific: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
Table 93 Asia Pacific: Influenza Diagnostics Market, By Country/Region, 2018–2025 (Usd Million)
Table 94 China: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 95 Japan: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 96 India: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 97 Roapac: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 98 Row: Influenza Diagnostics Market, By Test Type, 2018–2025 (Usd Million)
Table 99 Row: Traditional Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 100 Row: Molecular Diagnostics Market, By Type, 2018–2025 (Usd Million)
Table 101 Row: Inaat Market, By Type, 2018–2025 (Usd Million)
Table 102 Row: Influenza Diagnostics Market, By End User, 2018–2025 (Usd Million)
List Of Figures
Figure 1 Breakdown Of Primaries: Influenza Diagnostics Market
Figure 2 Data Triangulation Methodology
Figure 3 Market Size Estimation: Approach 1 (Revenue-Based Estimation)
Figure 4 Market Size Estimation: Approach 2 (Test Type-Based Estimation)
Figure 5 Influenza Diagnostics Market: Cagr Projections
Figure 6 Influenza Diagnostics Market: Cagr Projections From The Analysis Of Demand-Side Drivers, Opportunities, Restraints, & Challenges
Figure 7 Influenza Diagnostics Market, By Test Type, 2019
Figure 8 Influenza Diagnostic Market, By End User, 2019 Vs. 2025
Figure 9 Geographical Snapshot Of The Influenza Diagnostic Market
Figure 10 Increasing Prevalence Of Influenza To Drive Market Growth
Figure 11 Traditional Diagnostic Tests To Account For The Largest Share Of The North American Influenza Diagnostic Market In 2019
Figure 12 Hospitals Dominated The Influenza Diagnostics Market In 2019
Figure 13 Influenza Diagnostics Market: Drivers, Restraints, Opportunities, And Challenges
Figure 14 Impact Of The Covid-19 Outbreak On The Growth Of The Influenza Diagnostics Market
Figure 15 Influenza Diagnostics Market: Geographic Snapshot (2019)
Figure 16 Percentage Share Of Influenza Specimen Tested, By Region (2019)
Figure 17 North America: Influenza Diagnostics Market Snapshot, 2019
Figure 18 Asia Pacific: Influenza Diagnostics Market Snapshot
Figure 19 Rank Of Companies In The Influenza Diagnostics Market, 2019
Figure 20 Influenza Diagnostics Market (Global) Global Competitive Leadership Mapping, 2019
Figure 21 F. Hoffmann-La Roche Ag: Company Snapshot
Figure 22 Quidel Corporation: Company Snapshot
Figure 23 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 24 Company Snapshot: Abbott Laboratories, Inc.
Figure 25 Hologic, Inc.: Company Snapshot
Figure 26 Becton, Dickinson And Company: Company Snapshot
Figure 27 Danaher Corporation: Company Snapshot
Figure 28 Diasorin Sa: Company Snapshot
Figure 29 Meridian Bioscience: Company Snapshot
Figure 30 Luminex Corporation: Company Snapshot
Figure 31 Biomérieux Sa: Company Snapshot
Figure 32 Genmark Diagnostics, Inc.: Company Snapshot
Figure 33 Siemens Healthineers: Company Snapshot
Figure 34 Tecan Trading: Company Snapshot
